UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
To Section 13 or 15 of the
Securities Exchange Act of 1934.
Date of Report (Date of Earliest Event Reported): January 3, 2006
Commission File Number 0-31014
HEALTHEXTRAS, INC.
(Exact name of registrant as specified in its charter)
| | |
| Delaware | | 52-2181356 |
(State or other Jurisdiction of incorporation) | | (IRS Employer Identification No.) |
800 King Farm Boulevard
Rockville, Maryland 20850
(Address of principal executive offices)
(301) 548-2900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosure.
As announced in the Registrant’s press release dated January 3, 2006 attached as Exhibit 99.1 hereto, the Registrant’s Chief Executive Officer, David T. Blair is scheduled to present at the 24th Annual JPMorgan Healthcare Conference in San Francisco, California on Monday, January 9, 2006 and a live webcast and replays of the presentation will be available on the Corporate Home Page of HealthExtras website.
Item 9.01. Financial Statements and Exhibits.
(a) Financial statements of business acquired:
Not Applicable
(b) Pro forma financial information:
Not Applicable
(c) Exhibits:
| | |
Exhibit No.
| | Description
|
| 99.1 | | Press Release Dated January 3, 2006 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | | HEALTHEXTRAS, INC. |
| | |
| Dated: January 4, 2006 | | By: | | /s/ Michael P. Donovan
|
| | | | | Michael P. Donovan |
| | | | | Chief Financial Officer and Chief Accounting Officer |
